1-3 of 3
John Reitan, PharmD
Close
Sort by
Journal Articles

Ivosidenib Improves Overall Survival Relative to Standard Therapies in Relapsed or Refractory Mutant IDH1 AML: Results from Matched Comparisons to Historical Controls

Peter Paschka, MD, Hervé Dombret, MD, Xavier Thomas, MD PhD, Christian Recher, MD PhD, Sylvain Chantepie, MD, Pau Montesinos Fernandez, MD PhD, Evelyn Acuña-Cruz, MD, Paresh Vyas, MRCP, FRCP, FRCPath, Karl-Anton Kreuzer, MD, Michael Heuser, Klaus H. Metzeler, MD, Michael Dennis, MD, Bruno Quesnel, MD PhD, Mathilde Hunault-Berger, MDPhD, Mohamad Mohty, MD PhD, Arnaud Pigneux, MD PhD, Stephane De Botton, Daniela Weber, MSc, Konstanze Döhner, Gary Milkovich, PharmD, John Reitan, PharmD, Sarah C MacDonald, SD, Deborah Casso, MPH, Michael Storm, MSc, Hua Liu, PhD, Stephanie M. Kapsalis, BS, Eyal C. Attar, MD, Thomas Winkler, MD, Hartmut Döhner, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 18–19.
https://doi.org/10.1182/blood-2020-136957
Published: 2020
Journal Articles

Multi-Center Quantification Study of Time, Effort and Resource Utilization Associated with Autologous Peripheral Blood Stem Cell Mobilization: A European Perspective

Kai Hübel, MD, Nabih Azar, MD, David Dunning, MD, John Reitan, PharmD, Meghan E. Gallagher, MSc, Mohamad Mohty
Journal: Blood
Blood (2015) 126 (23): 2087.
https://doi.org/10.1182/blood.V126.23.2087.2087
Published: 2015
Journal Articles

The Burden of Blood Transfusion: A Utilization Analysis - A Pilot Study

John Reitan, PharmD, Fred J. Kudrik, MD, Kayleen Fox, RN, Sanatan Shreay, Arletta van Breda, RN, Patricia Corey-Lisle, PhD
Journal: Blood
Blood (2011) 118 (21): 4342.
https://doi.org/10.1182/blood.V118.21.4342.4342
Published: 2011